↓ Skip to main content

Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models

Overview of attention for article published in Investigational New Drugs, January 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

patent
14 patents

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
29 Mendeley
Title
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
Published in
Investigational New Drugs, January 2012
DOI 10.1007/s10637-011-9790-6
Pubmed ID
Authors

David A. Proia, Jim Sang, Suqin He, Donald L. Smith, Manuel Sequeira, Chaohua Zhang, Yuan Liu, Shuxia Ye, Dan Zhou, Ronald K. Blackman, Kevin P. Foley, Keizo Koya, Yumiko Wada

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Unknown 28 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 34%
Student > Master 4 14%
Student > Postgraduate 4 14%
Student > Bachelor 3 10%
Researcher 3 10%
Other 2 7%
Unknown 3 10%
Readers by discipline Count As %
Medicine and Dentistry 9 31%
Agricultural and Biological Sciences 6 21%
Biochemistry, Genetics and Molecular Biology 4 14%
Computer Science 2 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 7%
Unknown 5 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#4,765,602
of 23,056,273 outputs
Outputs from Investigational New Drugs
#166
of 1,175 outputs
Outputs of similar age
#41,376
of 244,728 outputs
Outputs of similar age from Investigational New Drugs
#4
of 9 outputs
Altmetric has tracked 23,056,273 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,175 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,728 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.